Tone the Bones of Your Chronic Liver Disease Patients

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 8, 2009, Pages 814-815

  Khan, Mahboob A ^a   Morgan, Sarah L ^a  

^a and Clinical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOCHEMICAL MARKER; CALCIUM; ESTROGEN; ETIDRONIC ACID; RHESUS D ANTIBODY; VIRUS RNA; VITAMIN D;

ACCIDENT PREVENTION; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; BONE DENSITY; BONE FRAGILITY; BONE REMODELING; BONE TURNOVER; CHRONIC LIVER DISEASE; COHORT ANALYSIS; DRUG CONTAMINATION; DRUG EFFECT; EDITORIAL; FALLING; GASTROINTESTINAL DISEASE; HEPATITIS C; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; MALABSORPTION; MORTALITY; PATIENT EDUCATION; PATIENT SAFETY; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; SCORING SYSTEM; SMOKING CESSATION; TOTAL HIP PROSTHESIS; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL;

BONE AND BONES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MASS SCREENING; OSTEOPOROSIS; PREVALENCE;

EID: 67949123174     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.04.013     Document Type: Editorial

References (17)

1. Cooper C., Campion G., and Melton III L.J. Hip fractures in the elderly: a world-wide projection. Osteoporosis Int 2 (1992) 285-289
2. Melton III L.J., Chrischilles E.A., Cooper C., et al. Perspective: How many women have osteoporosis?. J Bone Miner Res 7 (1992) 1005-1010
3. Randell A., Sambrook P.N., Nguyen T.V., et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis Int 5 (1995) 427-432
4. Reginster J.Y., and Burlet N. Osteoporosis: a still increasing prevalence. Bone 38 (2006) S4-S9
5. Cummings S.R., and Melton III J.R. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
6. Gullberg B., Johnell O., and Kanis J.A. Worldwide projections for hip fracture. Osteoporosis Int 7 (1997) 407-413
7. Sambrook P., and Cooper C. Osteoporosis. Lancet 367 (2006) 2010-2018
8. US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General (2004), US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD
9. Burge R.T., Dawson-Hughes B., Solomon D.H., et al. Incidence and economic burden of osteoporotic fractures in the United States, 2005-2025. J Bone Min Res 22 (2007) 465-475
10. Gasser R.W. Cholestasis and metabolic bone disease - a clinical review. Wien Med Wochenschr 158 (2008) 553-557
11. Nanda K., Ryan E., Murray B., et al. The effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol 7 (2009) 894-899
12. Luchi S., Fiorini I., Meini M., et al. Alterations of bone metabolism in patients with chronic C virus hepatitis. [in Italian]. Infez Med 13 (2005) 23-27
13. Carey E.J., Balan V., Kremers W.K., et al. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl 9 (2003) 1166-1173
14. Arase Y., Suzuki F., Suzuki Y., et al. Prolonged-efficacy of bisphosphonates in postmenopausal women with osteoporosis and chronic liver disease. [erratum in: 2008;80:1868]. J Med Virol 80 (2008) 1302-1307
15. Cohen S.M., Te H.S., and Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty 20 (2005) 460-466
16. American Gastroenterological Association. American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 125 (2003) 937-940
17. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis (2008), National Osteoporosis Foundation, Washington, DC